|
|
ICEID
2002 Webcast
Alphabetical listing by Presentation Title
A
B C D E
F G H I
J K L M N
O P Q R
S T U V
W X Y Z
| Alphabetical
listing by Presentation Title |
| A- |
|
The Acquisition
of Ciprofloxacin Resistance in Travel-Associated and Home-Acquired
Campylobacter jejuni Infection: A Case-Case Comparison
Iain Gillespie, Public Health Laboratory Service, London,
United Kingdom
Active Laboratory
Surveillance in Massachusetts
Bela Matyas, Massachusetts Department of Public Health,
Jamaica Plain, MA
Acute Respiratory
Virus Surveillance in Cairo and Alexandria, Egypt, July 2000-June
2001
Diaa Salman, U.S. Naval Medical Research Unit No 3.,
Cairo, Egypt
The Agent: Prions
as Emerging Infectious Particles
David Bolton, New York State Institute for Basic Research,
Staten Island, NY
AIDS
Michael Gottlieb, Los Angeles, CA
Analysis
of a Health Indicator Surveillance System: Its Ability to
Detect Annual Influenza Activity for the 1999-2000 and 2000-2001
Seasons Compared to Traditional Surveillance Systems
Ji-Eun Lee, Department of Defense Global Emerging Infections
System, Silver Spring, MD
Anthrax in the U.S. Postal System
Michele Pearson, CDC, Atlanta, GA
An Anthrax Outbreak
Averted: Public Health Response to a Contaminated Envelope
on Capitol Hill, Washington, DC, 2001
V.P. Hsu, CDC, Atlanta, GA
Anthrax
Vaccines
Arthur Friedlander, U.S. Army Medical Research Institute
of Infectious Diseases, Fort Detrick, MD
Antibiotic
Susceptibility and the Mechanisms of Macrolide Resistance
in Invasive Group B Streptococcus, Minnesota, 1998
and 2000
Joanne Bartkus, Minnesota Department of Health, Minneapolis,
MN
Antimicrobial
Resistance in Salmonella is Associated with Increased Hospitalization: NARMS 1996-2000
J.K. Varma, CDC, Atlanta, GA
Antimicrobial
Resistance in Salmonella
Serotype Typhimurium, R-Type ACSSuT,
is Associated with Bacteremia: NARMS 1996-2000
Kare Molbak, Statens Serum Institut, Copenhagen, Denmark
Are
Martha's Vineyard Landscapers at Increased Risk for Tularemia?—Massachusetts,
2001
K.A. Feldman, CDC, Fort Collins, CO
|
| B- |
|
Behind
the Scenes at the Emerging Infectious Disease Journal
Peter Drotman, CDC, Atlanta, GA
Brian Mahy, CDC, Atlanta, GA
Poly Potter, CDC, Atlanta, GA
Biology
of Aging
Steven Castle, University of California at Los Angeles,
Los Angeles, CA
Biology
of Immune Senescence
Richard Miller, University of Michigan, Ann Arbor,
MI
Bioterrorism
Richard Hoffman, University of Colorado Health Sciences
Center, Denver, CO
Bioterrorism
Preparedness: Lessons, Challenges, and Opportunities
James Hughes, Director, National Center for Infectious
Diseases, CDC, Atlanta, GA
Bioterrorism
2001: Lessons Learned
L.A. Cole, Rutgers University, Newark, NJ
Bringing
Dengue Prevention Down to Earth: Evaluation of a Head Start
Project in Puerto Rico
Carmen Pérez-Guerra, CDC, San Juan, PR
BT
Surveillance in NYC
Farzad Mostashari, Bureau of Communicable Disease,
New York City Department of Health, New York, NY
|
|
C-
|
|
Campylobacter coli—What’s the Big Deal?
Sarah O'Brien, Public Health Laboratory Service, London,
United Kingdom
CDC-PAHO
Collaboration: Surveillance of Emerging/Reemerging Diseases
in the Amazon and the Southern Cone Region
Gabriel Schmunis, Pan American Health Organization,
Washington, DC
CD
Electronic Surveillance in the UK and EU
Michael Catchpole, PHLS Communicable Disease Surveillance
Centre, London, United Kingdom
Challenges
in the Interpretation of Classical and Molecular Epidemiology
Results; Two Calicivirus Outbreaks Due to Oysters, Denmark at New Year 2000
Francois-Xavier Hanon, Statens Serum Institut, Copenhagen,
Denmark
Changes
in Circulating Enterovirus Serotypes in the United States,
2001
Andy Mullins, CDC, Atlanta, GA
Changing
Epidemiological Patterns of Salmonella serotype Enteritidis
in Barbados: Implications for Tourism and Trade
Lisa Indar-Harrinauth, University of the West Indies, St. Augustine,
Trinidad and Tobago
Clinical
and Epidemiologic Features of Smallpox
Stanley Foster, Rollins School of Public Health, Emory
University, Atlanta, GA
Clinical Management and Outcomes of Lyme Disease in Wisconsin
Daniel O'Leary, CDC, Fort Collins, CO
Clinical
Management of Smallpox Patients
Peter L. Havens, Medical College of Wisconsin, Milwaukee,
WI
Clusters
of Clinical Syndromes in Patients with Unexplained Encephalitis
Carol Glaser, California Department of Health Services,
Berkeley, CA
Computerized
Decision Support for Appropriate Antimicrobial Drug Prescribing
Matthew Samore, University of Utah, Salt Lake City,
UT
Controlling Antimicrobial
Resistance
Barry Farr, University of Virginia Hospital, Charlottesville,
VA
Coordinating
Environmental Public Health Practice with Epidemiology and
Laboratory Analysis: A Waterborne Outbreak of "Norwalk-like
Virus" in the Big Horn Mountains of Wyoming
Scott Seys, Wyoming Department of Health, Cheyenne,
WY
Cutaneous Anthrax in New York City
Marcelle Layton, New York Department of Health, New
York, NY
|
| D- |
|
Dengue Fever Outbreak in Hawaii—2001
Paul Effler, State of Hawaii Department of Health,
Honolulu, HI
Detection
and Genetic Analysis of Swine Hepatitis E Virus in Farm Waste
Theresa Cromeans, CDC, Atlanta, GA
Detection
and Typing of Enterovirus in Cerebrospinal Fluid
Blair Rosen, New York State Department of Health, Slingerlands,
NY
Detection of
La Crosse Virus in Cerebrospinal Fluid and Tissues by Reverse
Transcription-Polymerase Chain Reaction
Brett Slater, New York State Department of Health,
Slingerlands, NY
Determination of Allelic Diversity in the mec Operon of Methicillin-Resistant Staphylococcus
aureus in Wisconsin
Sanjay Shukla, Marshfield Medical Research Foundation,
Marshfield, WI
Development and
Evaluation of PCR-Based Diagnostics for Identification of
Salmonella O Antigens Based on the rfb Locus
Collette Fitzgerald, CDC, Atlanta, GA
A DoD Global Influenza
Surveillance Program
Linda Canas, Brooks Air Force Base, San Antonio, TX
|
| E- |
|
Ecological Niche
Modeling and Differentiation of Populations of Triatoma
Brasiliensis Neiva, 1911, the Most Important Chagas Disease
Vector in Northeastern Brazil (Hemiptera, Reduviidae, Triatominae)
Jane Costa, CDC, Atlanta, GA
Emergence of Canine Visceral Leishmaniasis in Dogs in North America
Zandra
Duprey, CDC, Atlanta, GA
The Emergence of
Infectious Diseases Among Wildlife and the Origin of Human
Zoonoses
Peter Daszak, Consortium for Conservation Medicine,
Palisades, NY
The
Emergence of Rift Valley Fever in the Arabian Peninsula, 2000
Hammam El Sakka, U.S. Naval Medical Research Unit No
3, Cairo, Egypt
The
Emergence of Serogroup Y Disease and the Epidemiology of Invasive
Meningococcal Disease in Colorado, 1997-2001
Lucinda Hammond, Colorado Department of Public Health
and Environment, Denver, CO
Emerging
and Reemerging STDs
Gail A. Bolan, California Department of Health Services,
Berkeley, CA
Emerging Fluoroquinolone
Resistance among Non-Typhoidal Salmonella in the United
States: NARMS 1996-2000
Shannon Rossiter, CDC, Atlanta, GA
Emerging
Infectious Diseases: The World Bank Perspective
O.K. Pannenborg, The World Bank, Washington, DC
Emerging Rickettsioses of the Thai-Myanmar Border
Philippe Parola, Harvard School of Public Health, Boston,
MA
Emerging
Vectorborne Disease: The Case of Yellow Fever
C.J. Peters, University of Texas, Medical Branch, Galveston,
TX
Emerging
Vectorborne Infections
Duane Gubler, CDC, Fort Collins, CO
Barry Beatty, Colorado State University, Fort Collins,
CO
Emerging Zoonoses:
A Novel Epizootic of Skunks Infected with a Bat Variant of Rabies
Mira Leslie, Arizona Department of Health Services,
Phoenix, AZ
Enhanced
Emergency Department Surveillance System Following the World Trade Disaster—New York City, September 14 to October 10,
2001
Debjani Das, New York Department of Health, New York,
NY
Enhanced
Laboratory-Based Surveillance of Shiga Toxin-Producing
Escherichia coli O157, the Netherlands
Yvonne Van Duynhoven, National Institute of Public
Health and the Environment, Bilthoven, The Netherlands
Epidemiology of
Raccoon and Skunk Rabies in the Eastern United States
Marta Guerra, CDC, Atlanta, GA
Epidemiology
of Shiga Toxin-Producing Escherichia coli (STEC) Infections in Connecticut, February 1, 2000-January 31, 2001
Q. Phan, Connecticut Department of Public Health, Hartford,
CT
Eradication
of Chagas Disease
Gabriel Schmunis, Pan American Health Organization,
Washington, DC
Eradication
of Dracunculiasis
Ernesto Ruiz-Tiben, CDC, Atlanta, GA
Eradication
of Lymphatic Filariasis and Onchocerciasis
Eric Ottesen, Lymphatic Filariasis Support Center,
Rollins School of Public Health, Emory University, Atlanta,
GA
Eradication
of T. solium Cysticercosis
Peter Schantz, CDC, Atlanta, GA
The Essential
Role of Behavioral and Social Sciences in the Prevention of
Emerging Infectious Diseases
Emily Zielinski-Gutiérrez, CDC, Fort Collins, CO
An Evaluation
of an Educational Videotape to Prevent Botulism among Alaska
Natives
Catherine Dentinger, CDC, Anchorage, AK
Evidence of Effectiveness of Egg Quality Assurance Programs, Mandatory Refrigeration, and Traceback Investigations to Mitigate Egg-Associated
Salmonella enteritidis Infections in the United States
Gerald Mumma, CDC, Atlanta, GA
|
| F- |
|
Failure to Detect C. pneumoniae in Atherosclerotic Specimens
Silvio Pitlik, Rabin Medical Center, Petah Tikvah, Israel
First Encounters with New Diseases: The Clinician's Perspective
Merle Sande, University of Utah, Salt Lake City, UT
First
Isolation of Human Metapneumovirus in Australia
Theo Sloots, Royal Children's Hospital and Royal Brisbane
Hospital, Brisbane, Australia
Foodborne
Disease
Leslie
Kux, U.S. Food and Drug Administration, Rockville, MD
Foodborne
Viruses in Europe: Web-Based Technologies for Investigation
of Transnational Outbreaks of Viral Gastroenteritis
Ben Lopman, Public Health Laboratory Service, London,
United Kingdom
Food
Safety: Perceived Risk and Public Trust
Carol Tucker Foreman, Consumer Federation of America,
Washington, DC
Foot and Mouth Disease
Christopher Bostock, Institute of Animal Health, Compton,
United Kingdom
|
| G- |
|
Genetic
Susceptibility to Infectious Diseases
Janet McNicholl, CDC, Atlanta, GA
Geographical Coherence of Influenza Epidemics in the U.S., France, and Australia: 1978-1998
Cecile Viboud, INSERM U444, Paris cedex 12, France
Global
Drug Resistance: The Case of Streptococcus pneumoniae
Keith Klugman, School of Public Health, Emory University,
Atlanta, GA
Global Fund to Fight HIV/AIDS, TB, and Malaria (New Political/Economic
Model for Addressing Priority Infectious Diseases)
Bill Steiger, U.S. Department of Health and Human Services,
Washington DC
Global Health, Emerging Infectious Diseases, and International Regulations
David Fidler, School of Law, Indiana University, Bloomington,
IN
The Globalization
of Our Food Supply: Implications for Emerging Infections
Michael Osterholm, University of Minnesota Academic
Health Center, Minneapolis, MN
Global
Migration and Emerging Infectious Diseases
Daniele Grondin, International Organization for Migration, Geneva, Switzerland
A Greenhouse
Study to Model Potential Field Use of Genetically Modified
Bacterial Symbionts for Chagas' Disease Control
Pritha Sen, CDC, Atlanta, GA
Group
B Meningococcal Vaccines
Gustavo Sierra, Finlay Institute, Havana, Cuba
|
| H- |
|
Hantavirus
Pulmonary Syndrome
Bruce Tempest, Gallup, NM
Health
Impact of the Salmonella enterica serotype Enteritidis Phage Type 4 Epidemic
Goutam Adak, Public Health Laboratory Service, London,
United Kingdom
High
Prevalence of Antibiotic Resistance in Enterotoxigenic
E. coli (ETEC); Minnesota 2000-2001
John Besser, Minnesota Department of Health, Minneapolis,
MN
HIV
in the Older Patient
Bradley Bender, University of Florida, Gainesville,
FL
|
| I- |
|
Impact
of Aging on the Epidemiology of Infections in Adults
Thomas Yoshikawa, Charles R. Drew University of Medicine
and Science, Los Angeles, CA
Impact
of Infectious Agents on Farming and Food Production
Peter J. Walker, CSIRO Livestock Industries, Indooroopilly,
Australia
Impact
of the BSE/vCJD Outbreak: U.S. Concerns for TSEs
Ermias Belay, CDC, Atlanta, GA
Implications
of Gene Transfer and Inducible Resistance for Successful Therapy
Abigail Salyers, American Society for Microbiology,
Washington, DC
Importance of
Bacillus anthracis Molecular Subtyping During the Recent
Multi-State Bioterrorism-Associated Anthrax Outbreak in the
United States
A. Hoffmaster, CDC, Atlanta, GA
Improving
Influenza and Pneumococcal Vaccination Rates for People 65+
in Rhode Island through Coalition Building Efforts
Thomas Bertrand, Rhode Island Department of Health,
Providence, RI
Incidence
and Type Distribution of Astrovirus Among Spanish Children
Alicia Sánchez-Fauquier, Centro Nacional de Microbiología,
Madrid, Spain
Increasing
Detection of Malaria in U.S. Hospitals Using the OptiMAL Rapid
Diagnostic Test
Carol Palmer, University of Florida, Gainesville, FL
Increasing
Water Vessel Use in Kenya
Philip Makutsa, CARE International in Kenya, Homa Bay,
Kenya
Influenza Surveillance
in New York State, 1998-2001
Marilyn Kacica, New York State Department of Health,
Albany, NY
Inhalational
Anthrax—New York City, October-November 2001
T.H. Holtz, New York City Department of Health, New
York, NY
Inhalation Anthrax in Florida
Steve Wiersma, Florida Department of Health, Tallahassee,
FL
Inhalation Anthrax of Unknown Source
James Hadler, Connecticut Department of Public Health,
Hartford, CT
Integrated Surveillance
and Control of Emerging Foodborne Diseases—The Successful
Danish Experience
Henrik Wegener, Danish Zoonosis Institute, Denmark
The
Interface of Animal and Human Health
Corrie Brown, College of Veterinary Medicine, University
of Georgia, Athens, GA
Intestinal
Anaerobic Bacteria in Early Rheumatoid Arthritis
Paavo Toivanen, Turku University, Turku, Finland
Investigation
of Q Fever in Bosnia-Herzegovina, 2000: An Example of International
Cooperation
Jennifer McQuiston, CDC, Atlanta, GA
In vivo Sensitivity
of Plasmodium falciparum to Chloroquine and Sulfadoxine/Pyrimethamine
During an Outbreak of Malaria in Burundi, 2001
François Dantoine, Epicentre, Paris, France
Is
Drinking Water a Risk Factor for Endemic Cryptosporidiosis
in the Immunocompetent General Population of the San Francisco
Bay Area?
Asheena Khalakdina, University of California at Berkeley,
Berkeley, CA
|
| K- |
|
Keynote
Gail Cassell, Eli Lilly and Company, Indianapolis,
IN
Peter Drotman, CDC, Atlanta, GA
James Hughes, Director, National Center for Infectious
Diseases, CDC, Atlanta, GA
Jeffrey
Koplan, Director, CDC, Atlanta, GA
Patty
Stonesifer, Executive Director, Bill and Melinda Gates
Foundation, Seattle, WA
|
| L- |
|
Laboratory Capacity
Brad Kay, WHO, Lyon, France
Ray Arthur, WHO, Geneva, Switzerland
Laboratory
Response in the Commonwealth of Virginia to the Intentional
Release of Bacillus anthracis
Denise
Pettit, Division of Consolidated Laboratory Services,
Richmond, VA
Lessons
Learned from Implementing Electronic Laboratory Reporting,
New York State
Perry Smith, New York State Department of Health, Albany,
NY
Letters from
Trenton: The Anthrax Investigation at the Source, New Jersey,
2001
J. Reefhuis, CDC, Atlanta, GA
Lyme
Disease Incidence in Wisconsin: A Comparison of State Reported
Rates with Rates from a Population-Based Cohort
Allison Naleway, Marshfield Medical Research Foundation,
Marshfield, WI
|
| M- |
|
Mapping of West Nile Virus Risk in the Northeast United States Using Multi-Temporal Meteorological Satellite Data
P. Bryon Backenson, New York State Department of Health,
Albany, NY
Microbiologic
Testing to Identify Shiga Toxin-Producing E. coli in
HUS Patients: FoodNet 1997-2001
C.R. Braden, CDC, Atlanta, GA
Microheterogenicity
of the Volgograd Clone of West Nile Virus
Alexander Platonov, Central Research Institute of Epidemiology,
Moscow, Russian Federation
Modeling Tuberculosis
Dissemination in Harris County, Texas, 1995-1998, with Spatial
Analysis and Geographic Information Systems (GIS)
Matthew Stone, University of Texas-Houston, Houston,
TX
A
Molecular Approach to the Epidemiology of Giardia duodenalis
in a Peruvian Shantytown
Paul Hoover, University of Arizona, Tucson, AZ
Molecular Characterization of a Multiresistant Strain of Salmonella enterica serotype
Typhimurium DT204b Responsible for an International Outbreak of Salmonellosis
E.J. Threlfall, Central Public Health Laboratory, London,
United Kingdom
Monitoring
of Human Exposure to Bacillus thuringiensis After
Aerial Applications for Insect Control
David Levin, University of Victoria, Victoria, BC,
Canada
Multi-Drug
Resistant Neisseria gonorrhoeae with Decreased Susceptibility
to Cefixime, Hawaii, 2001
Susan Wang, CDC, Atlanta, GA
Multiple
Array Technology to Look for mRNA Patterns Associated with
Disease and Pathogens
David Relman, Stanford University, Stanford, CA
Multi-State
Outbreak of Salmonella Senftenberg Infections Associated
with Green Grapes—Western States, 2001
A.B. Cronquist, CDC, Denver,
CO
|
| N- |
|
A Neighborhood Outbreak
of Q Fever Linked to a Goat Ranch in California
Michele Jay, California Department of Health Services,
Sacramento, CA
The New
Human Metapneumovirus
Albert Osterhaus, University of Rotterdam, Rotterdam,
The Netherlands
New Strategies on
the Old Ideas: Malaria Control Without Insecticides and Community
Participation in Aedes aegypti Control, Mexico's Experiences
Jorge F. Méndez-Galván, Ministry of Health, Mexico
City, Mexico
New
Technologies and Vaccine Development
Margaret Ann Liu, Bill and Melinda Gates Foundation,
Seattle, WA
|
| O- |
|
Opening
Session
Gail Cassell, Eli Lilly and Company, Indianapolis,
IN
Peter Drotman, CDC, Atlanta, GA
James Hughes, Director, National Center for Infectious
Diseases, CDC, Atlanta, GA
Jeffrey
Koplan, Director, CDC, Atlanta, GA
Patty
Stonesifer, Executive Director, Bill and Melinda Gates
Foundation, Seattle, WA
Outbreak
of Cryptococcus neoformans var. gattii in
a Restricted Zone in British Columbia
Mike Starr, University of British Columbia Centre for
Disease Control, Vancouver, BC, Canada
An
Outbreak of Salmonella Javiana Associated with Amphibian
Contact—Mississippi, 2001
Padmini Srikantiah, CDC, Atlanta, GA
Outbreak
of Viral Gastroenteritis and an Ill Baker Who Should Have
Known Better: Novel Application of E-mail for Rapid Investigation
Marc-Alain Widdowson, CDC, Atlanta, GA
Outbreaks
of Multidrug-Resistant Salmonella Serotype Typhimurium
Infections Associated with Small Animal Veterinary Facilities
in Idaho, Minnesota, and Washington, 1999
Jennifer
Wright, CDC, Atlanta, GA
Outbreaks
of Salmonellosis at Elementary Schools Associated with Dissection
of Owl Pellets
Fred Anderson, Washington County
Department of Public Health and Environment, Stillwater, NM
Outbreak
Surveillance: An Important Tool for Controlling Communicable
Diseases
Michael Baker, ESR, Wellington, New Zealand
Overview:
Disease Eradication
Walter Dowdle, Task Force for Child Survival and Development,
Atlanta, GA
|
| P- |
|
Patient Safety:
Applying Industrial Quality Models in Healthcare Settings
to Improve Outcomes
Julie Gerberding, CDC, Atlanta, GA
PER.C6: A Human
Designer Cell Line Providing a Pandemic-Proof Platform for
the Manufacturing of Safe Influenza Vaccines
Fons UytdeHaag, Crucell Holland BV, Leiden, The Netherlands
Postdiarrheal
Hemolytic Uremic Syndrome in New York State
H.H. Chang, New York State Department of Health, Albany,
NY
Prevalence
and Consequences of Fluoroquinolone-Resistant Campylobacter
Infections: NARMS 1997-2000
Jennifer McClellan, CDC, Atlanta, GA
Prevalence
of Hepatitis C and other Chronic Liver Disease Etiologies
in Primary Care Practices
Andre Sofair, Connecticut Emerging Infections Program,
New Haven, CT
Prevalence
of Salmonella spp. and Campylobacter spp. Following the Discontinued Use of Antimicrobial Growth Promoters in
Broilers and Swine in Denmark
Mary Evans, Danish Veterinary Institute,
Copenhagen, Denmark
Preventing
Human Disease by Controlling Pathogen Transmission in the
Animal Reservoir
Charles Rupprecht, CDC, Atlanta, GA
Prevention
Effectiveness
Martin Meltzer, CDC, Atlanta, GA
Anne Haddix, School of Public Health, Emory University,
Atlanta, GA
Prevention of Intravascular Catheter-Related Infections
Leonard Mermel, Rhode Island Hospital, Providence,
RI
Promoting
Appropriate Antimicrobial Drug Use in Developing Countries
Sayomporn Sirinavin, Mahidol University, Bangkok, Thailand
Prospects
for New Antimicrobial Drug Development: Industry Perspective
Gail Cassell, Eli Lilly and Company, Indianapolis,
IN
Protecting
the Nation's Health in an Era of Globalization: CDC's Global
Infectious Disease Strategy
Scott Dowell, CDC, Atlanta, GA
Proteomics
and Pathogen Discovery
Donald Hunt, University of Virginia, Charlottesville,
VA
Public
Health and Policy Implications of the Recent Large Drinking
Water Outbreaks in Canada
Andrea Ellis, Center for Infectious Diseases Prevention
and Control, Guelph, Ontario, Canada
Public
Health Laboratory Response to an Anthrax Incident in Connecticut
Donald Mayo, Connecticut State Health Department, Hartford,
CT
PulseNet
and Beyond
Balasubra Swaminathan, CDC, Atlanta, GA
PulseNet Experience:
Software Changes and Improvements to Online E. coli National
Database
Susan Hunter, CDC, Atlanta, GA
|
| Q- |
|
Q
Fever in the United States: Experience of Infectious Disease
Consultants and Comparison to National Reporting During 2000
Jennifer McQuiston, CDC, Atlanta, GA
Quinupristin/Dalfopristin-Resistant
Enterococcus faecium Isolated from Human Stools, Retail
Chicken, and Retail Pork: EIP Enterococci Project
Kathryn Gay, CDC, Atlanta, GA
|
| R- |
|
Randomized
Trial of Day Care Staff Education to Improve Parent Knowledge
and Attitudes Regarding Appropriate Antibiotic Use
Donita Croft, Wisconsin Division of Public Health and
CDC, Madison, WI
Rapid Adaptation
of a Serologic Assay for the Bioterrorism-Related Anthrax
Outbreak—October-December, 2001
C.M. Greene, CDC, Atlanta, GA
Rapid
Molecular Identification of B. anthracis in New York
State in Response to Recent Bioterrorism Incidents
Kimberlee Musser, New York, State Department of Health,
Albany, NY
Rapid
Screening and Identification of West Nile Virus in Captive
and Wild Birds Using Non-Invasive Environmental Samples and
a Portable TaqMan RT-PCR
Johnny Callahan, Tetracore, Inc., Gaithersburg, MD
Real-time
Fluorescence PCR Assays for the Detection and Characterization
of Heat-Labile and Heat-Stable Enterotoxin Genes from Enterotoxigenic
Escherichia coli
Nancy Strockbine, CDC, Atlanta, GA
Real-time
International Surveillance of Antimicrobial Resistance by
the Enter-net Surveillance Network
Ian Fisher, PHLS Communicable Disease Surveillance
Centre, London, United Kingdom
Recurrent Histoplasmosis
Outbreaks in Acapulco, Mexico
Yuri Roldán-Aragón, National Institute
of Medical Science and Nutrition, Mexico City, Mexico
Re-estimating the Global Burden of Typhoid Fever
John Crump, CDC, Atlanta, GA
Re-introduction
of Dengue 3 in Aragua, Venezuela: Clinical, Epidemiological and Laboratory Features of a New Outbreak
Guillermo Comach, Lardidev-Biomed, Universidad de Carabobo,
Maracay, Venezuela
The Reservoir:
Bovine Spongiform Encephalopathy and What's Been Done About
It
Dagmar Heim, Swiss Federal Veterinary Office, Bern-Liebefeld,
Switzerland
Risk Factors for Lyme Borreliosis: A German Case-Control Study
Andrea Ammon, Robert Koch Institute, Berlin, Germany
Risk
Factors for Sporadic Escherichia coli O157 Infections in the United States: A Case-Control Study in FoodNet Sites,
1999-2000
M.H. Kennedy, CDC, Atlanta, GA
The
Risk of Food and Water Contamination from Animal Manure
Christine Moe, Rollins School of Public Health, Emory
University, Atlanta, GA
The Role of Healthcare
Systems in Bioterrorism Preparedness
Trish Perl, Johns Hopkins Hospital, Baltimore, MD
Rotavirus
Vaccines in Development
Rajiv Bahn, All India Institute of Medical Sciences,
New Delhi, India
|
| S- |
|
Sesame-Seed Paste Caused an International Outbreak Due to Salmonella
Typhimurium DT104—The
Investigation in Norway
Ole Alvseike, Norwegian Institute of Public Health,
Oslo, Norway
Sex Workers
as Targets of and Agents for HIV/STI Prevention
Rafael Mazin, Pan American Health Organization HCA/HCP,
Washington, DC
Shared
Animal and Human Influenza Viruses: A Role in the Next Pandemic?
Kennedy Shortridge, University of Hong Kong, Queen
Mary Hospital, Hong Kong
Shigella
dysenteriae Serotype
1 in West Africa: Intervention Strategy for an Outbreak in
Sierra Leone, 1999-2000
Philippe Guerin, Epicentre, Paris, France
Smallpox
Vaccine and Vaccination Strategies
Joanne Cono, CDC, Atlanta, GA
Surveillance
for Patients with Acute Febrile Illness in Egypt
Salma Afifi, U.S. Naval Medical Research Unit No. 3,
Cairo, Egypt
Surveillance
of Livestock for Zoonotic Diseases and Veterinary Bio-Threat
Agents
William Hueston, College of Veterinary Medicine, University
of Minnesota, St. Paul, MN
Syndromic
Surveillance in a Managed Care Setting
Richard Platt, Ambulatory Care and Prevention, Harvard
Medical School, Boston, MA
|
| T- |
|
Threat
Letter Menace: The Fiji Experience
Kamal Kishore, Fiji School of Medicine, Suva, Fiji
Three Outbreaks of E. coli O157 Infections Due to Retail Ground Beef in Minnesota, 2000: Detection, Investigation, and Characteristics
Ellen Swanson, Minnesota Department of Health, Minneapolis,
MN
Transmission of the Main Viral Pathogens Causing Gastroenteritis, NLV, SLV, and Rotavirus
Yvonne van Duynhoven, National
Institute of Public Health and the Environment, Bilthoven,
The Netherlands
Trypanosomiasis as
a Reemerging Infection
Anne Moore, CDC, Atlanta, GA
Tuberculosis
Gene Deletion Typing, Not YATM ("Yet Another Typing Method")
Yves Goguet, Stanford University, Stanford, CA
|
| U- |
|
The
Unfolding Variant (vCJD) Epidemic
Robert Will, Western General Hospital, Edinburgh, United
Kingdom
Update
on the WHO Global Alert and Response Network
Ray Arthur, WHO, Geneva, Switzerland
Use
of Antiretroviral Agents in Developing Countries
Peter Mugyenyi, Joint Clinical Research Center, Kampala,
Uganda
Using CUSUM Techniques to Identify Influenza Outbreaks
Michael Stoto, The Rand Corporation, Arlington, VA
|
| V- |
|
Virology
and Diagnosis of Smallpox
Russell Regnery,
CDC, Atlanta, GA
Virology
of 1918 Flu Pandemic
Ann Reid, Armed Forces Institute of Pathology, Washington, DC
|
| W- |
|
Washington Clinical Laboratory Initiative—Assessment of Laboratory Practice
Jon Counts, University of Washington, Seattle, WA
West Nile Virus
First Transmission Season in Florida, 2001—More Than
400 Horse Cases and 170 Chicken Seroconversions but Only Sporadic
Human Disease
Carina Blackmore, Florida Department of Health, Jacksonville,
FL
West Nile
Virus Infection
Deborah Asnis, Brooklyn, NY
West
Nile Virus in New York City
Wilfredo Lopez, New York City Department of Health,
New York, NY
A WHO Global
Salm-Surv Retrospective Study Examining Salmonella Serotypes
in South America, 2000: Dominance of Salmonella Serotype
Enteritidis
WHO Global Salm-Surv South America Working Group, Instituto
INEI-ANLIS "Carlos G. Malbran", Buenos Aires, Argentina
The World
and Its Moving Parts: An Overview
Martin Cetron, CDC, Atlanta, GA
|
| Y- |
|
Yersinia
enterocolitica Surveillance
in Minnesota
Joni Scheftel, Minnesota Department of Health, Minneapolis,
MN
|
|
|
